北美分析儀器：市場佔有率分析、產業趨勢、統計數據、成長預測（2025-2030 年）

North America Analytical Instrumentation - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

出版日期: 2025年03月18日 | 出版商:

Mordor Intelligence | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

北美分析儀器市場規模預計在 2025 年為 96.8 億美元，預計到 2030 年將達到 128.4 億美元，預測期內（2025-2030 年）的複合年成長率為 5.81%。

對產品品質的日益關注、研發投入的增加以及嚴格的政府監管是推動北美分析儀器市場成長的主要因素。在預計預測期內，客戶意識的提高（尤其是在新興地區）和對多功能分析儀器的需求將進一步促進市場成長。

主要亮點

過去幾年中，政府（尤其是新興國家）對環境檢測和污染防治的舉措、北美對醫藥研發的投資增加、藥品安全方面的嚴格規定、原油和頁岩氣產量的擴大、對食品質量的日益關注以及質譜儀的技術進步等因素是推動研究市場成長的主要因素。
此外，開發行動電話、電動車、能源系統和其他系統和設備電池的公司依靠分析儀器來提高測試、儲存容量和生產產量，以創造更有效率、清潔和安全的能源來源。公司正在使用電子顯微鏡技術來了解原子尺度的結構，並結合光譜工具來發現材料中導致缺陷或低效率的關鍵變化。
然而，分析設備的高成本正在抑制市場的成長。此外，除了設備成本外，還涉及人力、維護、實驗室費用等各種成本，抑制了市場的成長。此外，功能和性能的日益複雜化、技術進步和創新系統也推高了分析儀器的成本。
市場上的供應商擴大將分析作為支持全球主要受監管行業營運的行業的目標。協同工作擴大被應用於製藥等行業，這對於業務成長至關重要。
最近爆發的新冠肺炎疫情為被調查市場帶來了巨大的需求。在新冠疫情期間，加速研究的必要性變得更加迫切，大眾期待科學界取得前所未有的進展。

北美分析設備市場趨勢

生命科學領域預計將佔據主要市場佔有率

生命科學是分析儀器產業中佔比最大的領域，佔整個產業的四分之一。生命科學涵蓋 13 個不同的技術領域，並涵蓋使用光譜、原子光譜和分子光譜等分析工具的廣泛應用。這為通用儀器應用和利基研究系統的發展提供了巨大的機會。
對次世代定序（NGS）的需求持續強勁，影響定序領域並推動核酸樣品製備領域的強勁需求。隨著基因組技術超越基礎研究進入生物醫學領域，這種成長在公共和私營部門都很明顯。這種驚人的成長預計將對分析儀器解決方案產生巨大的需求，因為它可以幫助製藥公司遵守有關藥品安全的嚴格規定。
從地區來看，中國對生命科學設備的需求最高，主要受該國精準醫療計畫的推動。美國是第二大生命科學市場。由於COVID-19的經濟影響，對分析儀器的需求正在迅速轉向臨床和製藥領域。
此外，對藥物生物相似藥、植物藥和再生藥物的需求大幅增加預計將推動業界採用分析儀器解決方案。
安捷倫科技等公司是美國領先的醫療保健和實驗室分析儀器製造商之一，透過提供分析儀器和消耗品來進行研究、實驗和做出準確的診斷，為該市場提供服務。
市場正在經歷多項策略發展，例如新產品開發、合併和合作，這表明該領域對分析儀器的採用有所增加。例如，2021 年 11 月，賽默飛世爾科技宣布推出新的質譜 (MS) 儀器、工作流程和軟體。 Thermo Scientific Orbitrap Exploris MX 質譜檢測器器使生物製藥實驗室能夠執行多屬性方法 (MAM)、進行完整單株抗體分析、進行寡核苷酸品質測定以及進行胜肽圖分析。

精準醫療發展推動市場發展

精準醫療的出現，開發個人化藥物和治療方法，是推動實驗室分析設備市場成長的最重要因素之一。
擴大精準醫療的可近性需要更廣泛地參與臨床試驗，以加速獲得新的標靶治療。這需要在臨床試驗期間執行多種功能的分析設備。
臨床研究領域的這種需求促使 FDA核准了一系列針對個人特定特徵的藥物，例如 Lynparza 和 Blincyto。這些發展預計將刺激分析儀器市場的需求。
該市場的供應商正專注於擴大其在精準醫療產業的產品供應，主要透過合作夥伴關係和協作。例如，2021 年 7 月，Sciex 推出了 ZenoTOF 7600 系統，這是一款質譜液相層析質譜/質譜 (LC-MS/MS) 儀器，同時包含 Xenotrap 和電子活化解離 (EAD) 碎裂技術。

北美分析儀器行業概況

預計在整個預測期內，北美分析儀器市場的競爭程度將保持中等偏高。雖然市場上的大型供應商已經獲得了更詳細的產品系列併滿足了各種客戶的需求，但較小的供應商則處於利基市場，提供客製化和客戶特定的訂單。主要公司包括安捷倫科技公司、馬爾文帕納科有限公司（思百吉公司）、珀金埃爾默公司、賽默飛世爾科技公司和島津製作所公司。

2021 年 11 月－安捷倫科技宣布推出用於奈米顆粒溶解測試的 NanoDisSystem。安捷倫儀器和軟體組合使您能夠透過專用、自動化且審核的工作流程滿足 21 CFR Part 11 和其他法規的要求。
2021 年 10 月－布魯克公司宣布推出大樣本 Dimension IconIR紅外線光譜和化學成像系統。該平台將 Dimension Icon AFM 與 nanoIR熱感AFM-IR 技術相結合，為化學和材料特性映射樹立了亞 10nm 化學成像解析度的新標準。

其他福利：

Excel 格式的市場預測 (ME) 表
3個月的分析師支持

The rising concerns regarding product quality, increasing investments in R&D, and stringent government regulations are some major factors driving the growth of the North American analytical instrumentation market. The rising customer awareness, especially in emerging regions, and the need for analytical instruments across multiple sectors, are further expected to augment the market's growth over the forecast period.

Key Highlights

In the past few years, the growth in the market studied was primarily driven by factors such as government initiatives for environmental testing and pollution control and especially in developing countries, increasing investments in North America's pharmaceutical R&D, stringent regulations on drug safety, expansion of crude and shale gas production, increasing focus on the quality of food products, and technological advancements in mass spectrometers.
Further, companies developing batteries for mobile phones, electric vehicles, energy systems, and other systems/devices depend on analytical instruments to enhance testing, storage potential, and output to create more efficient, cleaner, and safer energy sources. Companies use electron microscopy technologies to understand structures that level down at the atomic scale, along with spectroscopy tools to discover critical changes in materials that cause defects and inefficiency.
However, the high cost of analytical instruments restrains the growth of the studied market. Furthermore, along with the cost of instruments, various other costs are associated, such as staffing, maintenance, and laboratory expenses, thereby restraining the market's growth. Moreover, the advancement in features and functionalities, technological advancements, and innovative systems are adding to the cost of analytical instruments.
The market vendors are increasingly targeting analytics, mainly to support industries operating in regulated sectors across the world. To target applications in industries such as pharmaceuticals, collaborative work is increasingly witnessing adoption, which is critical for business growth.
The recent COVID-19 outbreak resulted in significant demand in the market studied. The need for accelerated research has significantly increased during the COVID-19 outbreak, and the public expects unprecedented progress from the scientific community.

North America Analytical Instrumentation Market Trends

Life Sciences Segment Expected to Hold Significant Market Share

Life sciences account for the largest share in the analytical instrument industry, representing a quarter of the entire industry. Life sciences comprise more than 13 individual technology segments, encompassing a wide range of applications using analytical tools such as spectrometry, atomic spectroscopy, and molecular spectroscopy. This provides significant opportunities to grow both general instrument applications and niche research systems.
Demand for Next Generation Sequencing (NGS) continues to flourish, impacting the sequencing segment and driving strong demand in the nucleic acid sample preparation segment. This growth was evident in the public and private sectors, as genomics technology went beyond basic research to reach the biomedical domain. Such tremendous growth is expected to create a significant demand for analytical instrumentation solutions, as it helps pharmaceutical companies comply with stringent regulations on drug safety.
Geographically, China has the highest demand for life science instruments, majorly propelled by the country's precision medicine initiative. It is followed by the United States, which is the largest life science market. Owing to the impact of COVID-19 on the economy, the demand for analytical tools is rapidly shifting to the clinical and pharmaceutical segments.
Also, a significant rise in demand for pharmaceutical biosimilars, phytopharmaceuticals, and regenerative medicine, is expected to aid in the adoption of analytical instrumentation solutions in the industry.
The companies such as Agilent Technologies are just one of the leading manufacturers of analytical instruments for healthcare and research laboratories in the United States that contributes to this market by offering analytical instruments and supplies to conduct research and experiments and make accurate diagnoses.
The market is witnessing several strategic developments such as new product developments, mergers, and collaboration that suggest the increase in the adoption of analytical tools in the segment. For instance, in November 2021, Thermo Fisher Scientific launched its new mass spectrometry (MS) instruments, workflows, and software. The Thermo Scientific Orbitrap Exploris MX mass detector allows biopharmaceutical laboratories to implement the multi-attribute method (MAM), perform intact monoclonal antibody analysis, conduct oligonucleotide mass determination, and carry out peptide mapping.

Development of Precision Medicines to Drive the Market Growth

The emergence of precision medicine to develop personalized medicines and therapies is one of the most important factors driving the laboratory analytical instruments market's growth.
Increased access to precision medicine requires more widespread participation in clinical trials to accelerate the availability of new targeted therapies. This requires the analytical instrument to perform various functions in clinical trials.
Owing to such needs in the clinical research domain, the FDA approved various drugs, such as Lynparza and Blincyto, that are tailored to specific characteristics of an individual. Such developments are expected to boost the demand for the analytical instruments market.
Vendors in the market are focusing on expanding their offerings in the precision medicine industry, primarily through partnerships and collaborations. For instance, in July 2021, Sciex launched the ZenoTOF 7600 System, a mass liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) instrument that includes both Zeno trap and electron activated dissociation (EAD) fragmentation.

North America Analytical Instrumentation Industry Overview

The degree of competition in the North America Analytical Instrumentation Market is anticipated to be moderately high over the forecast period. The major vendors in the market garner more in-depth product portfolios, catering to different customer requirements, whereas smaller vendors operate in niche segments providing customizations and customer-specific orders. Key players include Agilent Technologies Inc., Malvern Panalytical Ltd (Spectris Company), PerkinElmer Inc., Thermo Fisher Scientific, and Shimadzu Corporation.

November 2021 - Agilent Technologies announced the introduction of the NanoDisSystem for nanoparticle dissolution testing. Combining Agilent instrumentation and software to enable customers to meet 21 CFR Part 11 and other regulations through its application, the new NanoDisSystem delivers a dedicated workflow that is automatable and auditable.
October 2021 - Bruker Corporation announced the launch of its large sample Dimension IconIRnanoscale infrared spectroscopy and chemical imaging systems. The platform combines Dimension Icon AFM and nanoIR photothermal AFM-IR technology to establish new chemical and material property mapping standards with sub-10nm chemical imaging resolution.

Additional Benefits:

The market estimate (ME) sheet in Excel format
3 months of analyst support

1 INTRODUCTION

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview
4.2 Industry Value Chain Analysis
4.3 Industry Attractiveness - Porter's Five Forces Analysis
- 4.3.1 Bargaining Power of Suppliers
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of New Entrants
- 4.3.4 Intensity of Competitive Rivalry
- 4.3.5 Threat of Substitutes
4.4 Market Drivers
- 4.4.1 Development of Precision Medicines
4.5 Market Restraints
- 4.5.1 High Initial Cost
4.6 Assessment of the Impact of COVID-19 on the Industry

5 MARKET SEGMENTATION

5.1 By Product Type
- 5.1.1 Chromatography
- 5.1.2 Molecular Analysis Spectroscopy
- 5.1.3 Elemental Analysis Spectroscopy
- 5.1.4 Mass Spectroscopy
- 5.1.5 Analytical Microscopes
- 5.1.6 Other Product Types
5.2 By End-user Industry
- 5.2.1 Life Sciences
- 5.2.2 Chemical and Petrochemical
- 5.2.3 Material Sciences
- 5.2.4 Food Testing
- 5.2.5 Oil and Gas
- 5.2.6 Research and Academia
- 5.2.7 Other End-Users

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles
- 6.1.1 Agilent Technologies Inc.
- 6.1.2 Bruker Corporation
- 6.1.3 Perkinelmer Inc.
- 6.1.4 Thermo Fisher Scientific Inc.
- 6.1.5 Shimadzu Corporation
- 6.1.6 Malvern Panalytical Ltd (Spectris Plc)
- 6.1.7 Mettler Toledo International
- 6.1.8 Waters Corporation
- 6.1.9 Bio-Rad Laboratories Inc.